Nicotine accelerates diabetes-induced retinal changes

Current Eye Research

Volumn 40, Issue 4, 2015, Pages 368-377

  Boretsky, Adam ^a   Gupta, Praveena ^b   Tirgan, Nima ^b   Liu, Rong ^b,c   Godley, Bernard F ^b   Zhang, Wenbo ^b   Tilton, Ronald G ^a,b   Motamedi, Massoud ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetes; Neurons; Nicotine; Retinal thickness; SD OCT; SLO

Indexed keywords

GLUCOSE; NICOTINE; CHOLINERGIC RECEPTOR STIMULATING AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; GLUCOSE BLOOD LEVEL; MALE; MORPHOLOGY; MULTIMODAL IMAGING; NONHUMAN; OPTIC DISK; PRIORITY JOURNAL; RAT; RETINA BIPOLAR GANGLION CELL; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; RODENT MODEL; SCANNING LASER OPHTHALMOSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SPRAGUE DAWLEY RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CONFOCAL MICROSCOPY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; RETINA NERVE CELL;

ANIMALS; CELL SURVIVAL; CHOLINERGIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; MALE; MICROSCOPY, CONFOCAL; MULTIMODAL IMAGING; NICOTINE; OPHTHALMOSCOPY; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84925341287     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.924147     Document Type: Article

References (57)

1. Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012;60:428-431.
2. Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep 2010;10:380-384.
3. Tarr JM, Kaul K, Wolanska K, Kohner EM, Chibber R. Retinopathy in diabetes. Adv Exp Med Biol 2012;771: 88-106.
4. Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38: 2355-2365.
5. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-791.
6. Lieth E, Gardner TW, Barber AJ, Antonetti DA, Group PSRR. Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 2000;28:3-8.
7. Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000;17:463-471.
8. Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 2001;44:791-804.
9. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002;47:S253-S262.
10. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res 2002;74:615-625.
11. Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, et al. Apoptotic death of photoreceptors in the streptozo-tocin-induced diabetic rat retina. Diabetologia 2003;46: 1260-1268.
12. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:283-290.
13. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 2004;45:3330-3336.
14. van Dijk HW, Kok PH, Garvin M, Sonka M, Devries JH, Michels RP, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009;50:3404-3409.
15. van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010;51:3660-3665.
16. Bronson-Castain KW, Bearse MA, Neuville J, Jonasdottir S, King-Hooper B, Barez S, et al. Early neural and vascular changes in the adolescent type 1 And type 2 diabetic retina. Retina 2012;32:92-102.
17. Ghirlanda G, Di Leo MA, Caputo S, Falsini B, Porciatti V, Marietti G, et al. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes 1991;40:1122-1127.
18. Di Leo MA, Falsini B, Caputo S, Ghirlanda G, Porciatti V, Greco AV. Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia 1990;33: 726-730.
19. Sima AA, Zhang WX, Cherian PV, Chakrabarti S. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 1992;35: 602-607.
20. Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT. Early visual deficits in streptozotocin-induced diabetic long evans rats. Invest Ophthalmol Vis Sci 2013;54: 1370-1377.
21. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998;42:535-547.
22. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye (Lond) 2005;19: 935-944.
23. Neuner B, Komm A,Wellmann J, Dietzel M, Pauleikhoff D, Walter J, et al. Smoking history and the incidence of agerelated macular degeneration - results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict Behav 2009;34:938-947.
24. Cano M, Thimmalappula R, Fujihara M, Nagai N, Sporn M, Wang AL, et al. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and age-related macular degeneration. Vision Res 2010;50: 652-664.
25. Edwards R, Thornton J, Ajit R, Harrison RA, Kelly SP. Cigarette smoking and primary open angle glaucoma: a systematic review. J Glaucoma 2008;17:558-566.
26. Zhang X, Kahende J, Fan AZ, Barker L, Thompson TJ, Mokdad AH, et al. Smoking and visual impairment among older adults with age-related eye diseases. Prev Chronic Dis 2011;8:A84.
27. Kelly SP, Thornton J, Edwards R, Sahu A, Harrison R. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005;31:2395-2404.
28. Galor A, Lee DJ. Effects of smoking on ocular health. Curr Opin Ophthalmol 2011;22:477-482.
29. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003;45:405-413.
30. Lois N, Abdelkader E, Reglitz K, Garden C, Ayres JG. Environmental tobacco smoke exposure and eye disease. Br J Ophthalmol 2008;92:1304-1310.
31. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 2001;30:540-546.
32. Karamanos B, Porta M, Songini M, Metelko Z, Kerenyi Z, Tamas G, et al. Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia 2000;43:348-355.
33. Mühlhauser I, Bender R, Bott U, Jörgens V, Grüsser M, Wagener W, et al. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med 1996;13:536-543.
34. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, et al. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 1991;265:614-617.
35. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-839.
36. Suñer IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez EP, Pereira-Simon S, Cousins SW. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2004;45: 311-317.
37. Yang L, Gong H, Wang Y, Yin H, Chen P, Zhang H. Nicotine alters morphology and function of retinal pigment epithelial cells in mice. Toxicol Pathol 2010;38: 560-567.
38. Varghese SB, Reid JC, Hartmann EE, Keyser KT. The effects of nicotine on the human electroretinogram. Invest Ophthalmol Vis Sci 2011;52:9445-9451.
39. Gundogan FC, Durukan AH, Mumcuoglu T, Sobaci G, Bayraktar MZ. Acute effects of cigarette smoking on pattern electroretinogram. Doc Ophthalmol 2006;113: 115-121.
40. Gundogan FC, Erdurman C, Durukan AH, Sobaci G, Bayraktar MZ. Acute effects of cigarette smoking on multifocal electroretinogram. Clin Experiment Ophthalmol 2007;35:32-37.
41. Huber G, Beck SC, Grimm C, Sahaboglu-Tekgoz A, Paquet-Durand F, Wenzel A, et al. Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest Ophthalmol Vis Sci 2009;50:5888-5895.
42. Zhou Y, Sheets KG, Knott EJ, Regan CE, Tuo J, Chan CC, et al. Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse. Exp Eye Res 2011;93:636-648.
43. Fischer MD, Huber G, Beck SC, Tanimoto N, Muehlfriedel R, Fahl E, et al. Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS One 2009;4:e7507.
44. Knott EJ, Sheets KG, Zhou Y, Gordon WC, Bazan NG. Spatial correlation of mouse photoreceptor-RPE thickness between SD-OCT and histology. Exp Eye Res 2011;92: 155-160.
45. Mayer MA, Hornegger J, Mardin CY, Tornow RP. Retinal nerve fiber layer segmentation on FD-OCT scans of normal subjects and glaucoma patients. Biomed Opt Express 2010; 1:1358-1383.
46. Luan H, Roberts R, Sniegowski M, Goebel DJ, Berkowitz BA. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006;47:320-328.
47. Gabriele ML, Ishikawa H, Schuman JS, Bilonick RA, Kim J, Kagemann L, et al. Reproducibility of spectral-domain optical coherence tomography total retinal thickness measurements in mice. Invest Ophthalmol Vis Sci 2010;51: 6519-6523.
48. Hua P, Feng W, Ji S, Raij L, Jaimes EA. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol 2010;299:F732-F739.
49. Tirgan N, Kulp GA, Gupta P, Boretsky A, Wiraszka TA, Godley B, et al. Nicotine exposure exacerbates development of cataracts in a type 1 diabetic rat model. Exp Diabetes Res 2012;2012:349320. doi: 10.1155/2012/349320.
50. Biallosterski C, van Velthoven ME, Michels RP, Schlingemann RO, DeVries JH, Verbraak FD. Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. Br J Ophthalmol 2007;91: 1135-1138.
51. Cho HY, Lee DH, Chung SE, Kang SW. Diabetic retinopathy and peripapillary retinal thickness. Korean J Ophthalmol 2010;24:16-22.
52. Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore T, et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 2002;12:482-487.
53. Ciresi A, Amato MC, Morreale D, Morreale R, Di Giovanna F, Caritá S, et al. OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. Acta Diabetol 2010;47:259-263.
54. Morgado PB, Chen HC, Patel V, Herbert L, Kohner EM. The acute effect of smoking on retinal blood flow in subjects with and without diabetes. Ophthalmology 1994; 101:1220-1226.
55. Bearse MA, Han Y, Schneck ME, Barez S, Jacobsen C, Adams AJ. Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy. Invest Ophthalmol Vis Sci 2004;45:3259-3265.
56. Han Y, Adams AJ, Bearse MA, Schneck ME. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 2004;122:1809-1815.
57. Abrá moff MD, Garvin MK, Sonka M. Retinal imaging and image analysis. IEEE Rev Biomed Eng 2010;3: 169-208.